Meeting
2020 Gastrointestinal Cancers Symposium
Palliative systemic chemotherapy with or without pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin (PIPAC C/D) for gastric cancer with peritoneal metastasis: A propensity score analysis.
Authors
Vladimir Khomiakov
Р.A. Hertsen Moscow Research Oncological Institute–National Medical Research Centre of Radiology, Moscow, Russian Federation
Vladimir Khomiakov , Christoph Meisner , Andrey Ryabov , Larisa Bolotina , Anna Utkina , Ilia Kolobaev , Dmitry Sobolev , Anna Chayka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 380)
Abstract #
380
Poster Bd #
E13
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis (PIPAC-GA1).
First Author: Florian Struller
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2020 Gastrointestinal Cancers Symposium
Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis.
First Author: Mehdi Javanbakht
Poster
2018 Gastrointestinal Cancers Symposium
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for nonresectable peritoneal carcinomatosis from gastric cancer.
First Author: Mohammad Alyami